Bill

Bill > HB897


GA HB897

Urgent Insulin Safety Net Program Act; enact


summary

Introduced
04/02/2025
In Committee
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT To amend Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to public assistance, so as to make insulin accessible to individuals who are in urgent need of a short-term affordable insulin supply; to provide for a short title; to provide for definitions; to require a pharmacy to dispense a 30 day supply of insulin to an eligible individual through the Urgent Insulin Safety Net Program; to allow a pharmacy to collect a copayment for insulin dispensed through such program; to provide for a pharmacy to submit a claim for payment or a replacement supply after dispensing insulin through such program; to require a manufacturer to reimburse or resupply a pharmacy dispensing insulin through such program; to provide for a pharmacy to dispense one additional short-term affordable urgent insulin supply under certain conditions; to require the Department of Community Health to develop an application form, an information sheet, and satisfaction surveys regarding such program; to require a manufacturer of insulin to establish procedures to make insulin available under such program; to provide for enforcement, penalties, and appellate procedures; to provide for reporting; to provide for related matters; to provide for an effective date; to repeal conflicting laws; and for other purposes.

AI Summary

This bill establishes the Urgent Insulin Safety Net Program in Georgia, designed to help residents with urgent insulin needs who lack adequate health coverage. Under the program, eligible individuals can receive a 30-day supply of insulin from a pharmacy for a maximum copayment of $35, with the option to receive one additional 30-day supply within 12 months if they are in the process of applying for medical assistance. To qualify, individuals must be Georgia residents, not have comprehensive insulin coverage, and have less than a week's insulin supply. Manufacturers of insulin are required to reimburse pharmacies for the cost of insulin and provide replacement supplies, establish informational hotlines, and report annually on program usage. The program includes provisions for developing informational materials about accessing medical assistance and healthcare resources, as well as satisfaction surveys for both patients and pharmacies. Pharmacies must notify a patient's healthcare provider when dispensing insulin and retain application records. The bill includes penalties for fraudulent program use and non-compliance by manufacturers, with potential administrative fines escalating to $600,000 per month for continued non-compliance. The program is set to become effective on July 1, 2025, with ongoing reporting requirements to assess its effectiveness.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

House First Readers (on 04/04/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...